Prof. Serge Muyldermans (VUB) - Salle Couvreur (73/0) - 1pm

Bruxelles Woluwe

October 15, 2018

Rapid identification and development of nanobody-based drugs.

Related publications:

  • D’Huyvetter M, Lahoutte T, Muyldermans S, Devoogdt Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy. Expert Opinion on Drug Delivery 11,(12), 1939-1954, 2014
  • Muyldermans S. Nanobodies – Natural single domain antibodies. Ann Rev Biochem 82, 775-797, 2013

Info : prof. Rita Vanbever